These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18469864)

  • 1. Identification and characterization of novel AML1-ETO fusion transcripts in pediatric t(8;21) acute myeloid leukemia: a report from the Children's Oncology Group.
    LaFiura KM; Edwards H; Taub JW; Matherly LH; Fontana JA; Mohamed AN; Ravindranath Y; Ge Y;
    Oncogene; 2008 Aug; 27(36):4933-42. PubMed ID: 18469864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. t(8;21;14)(q22;q22;q24) is a novel variant of t(8;21) with chimeric transcripts of AML1-ETO in acute myelogenous leukemia.
    Ishida F; Ueno M; Tanaka H; Makishima H; Suzawa K; Hosaka S; Hidaka E; Ishikawa M; Yamauchi K; Kitano K; Kiyosawa K
    Cancer Genet Cytogenet; 2002 Jan; 132(2):133-5. PubMed ID: 11850074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia.
    Miyamoto T; Nagafuji K; Akashi K; Harada M; Kyo T; Akashi T; Takenaka K; Mizuno S; Gondo H; Okamura T; Dohy H; Niho Y
    Blood; 1996 Jun; 87(11):4789-96. PubMed ID: 8639850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B.
    Frank R; Zhang J; Uchida H; Meyers S; Hiebert SW; Nimer SD
    Oncogene; 1995 Dec; 11(12):2667-74. PubMed ID: 8545124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis.
    Rhoades KL; Hetherington CJ; Rowley JD; Hiebert SW; Nucifora G; Tenen DG; Zhang DE
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11895-900. PubMed ID: 8876234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the polymerase chain reaction in the detection of AML1/ETO fusion transcript in t(8;21).
    Kwong YL; Chan V; Wong KF; Chan TK
    Cancer; 1995 Feb; 75(3):821-5. PubMed ID: 7828132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AML1/ETO proteins control POU4F1/BRN3A expression and function in t(8;21) acute myeloid leukemia.
    Dunne J; Gascoyne DM; Lister TA; Brady HJ; Heidenreich O; Young BD
    Cancer Res; 2010 May; 70(10):3985-95. PubMed ID: 20460523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The leukemogenic t(8;21) fusion protein AML1-ETO controls rRNA genes and associates with nucleolar-organizing regions at mitotic chromosomes.
    Bakshi R; Zaidi SK; Pande S; Hassan MQ; Young DW; Montecino M; Lian JB; van Wijnen AJ; Stein JL; Stein GS
    J Cell Sci; 2008 Dec; 121(Pt 23):3981-90. PubMed ID: 19001502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction.
    Kozu T; Miyoshi H; Shimizu K; Maseki N; Kaneko Y; Asou H; Kamada N; Ohki M
    Blood; 1993 Aug; 82(4):1270-6. PubMed ID: 8353289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.
    Yan M; Kanbe E; Peterson LF; Boyapati A; Miao Y; Wang Y; Chen IM; Chen Z; Rowley JD; Willman CL; Zhang DE
    Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner.
    Elsässer A; Franzen M; Kohlmann A; Weisser M; Schnittger S; Schoch C; Reddy VA; Burel S; Zhang DE; Ueffing M; Tenen DG; Hiddemann W; Behre G
    Oncogene; 2003 Aug; 22(36):5646-57. PubMed ID: 12944913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of genomic AML1-ETO fusions in childhood leukemia.
    Xiao Z; Greaves MF; Buffler P; Smith MT; Segal MR; Dicks BM; Wiencke JK; Wiemels JL
    Leukemia; 2001 Dec; 15(12):1906-13. PubMed ID: 11753612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZFP36L2, a novel AML1 target gene, induces AML cells apoptosis and inhibits cell proliferation.
    Liu J; Lu W; Liu S; Wang Y; Li S; Xu Y; Xing H; Tang K; Tian Z; Rao Q; Wang M; Wang J
    Leuk Res; 2018 May; 68():15-21. PubMed ID: 29518627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of minimal residual disease in acute myeloid leukemia with t(8;21)(q22;q22).
    Zhang L; Li Q; Li W; Liu B; Wang Y; Lin D; Zhou C; Li C; Wang J; Mi Y
    Int J Hematol; 2013 Jun; 97(6):786-92. PubMed ID: 23613269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translocation (8;17;15;21)(q22;q23;q15;q22) in acute myeloid leukemia (M2). a four-way variant of t(8;21).
    Vieira L; Oliveira V; Ambrósio AP; Marques B; Pereira AM; Hagemeijer A; Boavida MG
    Cancer Genet Cytogenet; 2001 Jul; 128(2):104-7. PubMed ID: 11463447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD7+ near-tetraploid acute myeloblastic leukemia M2 with double t(8;21)(q22;q22) translocations and Aml1/ETO rearrangements detected by fluorescence in situ hybridization analysis.
    Yamamoto K; Nagata K; Kida A; Tsurukubo Y; Hamaguchi H
    Int J Hematol; 2001 Oct; 74(3):316-21. PubMed ID: 11721969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AML1-ETO inhibits acute myeloid leukemia immune escape by CD48.
    Wang Z; Guan W; Wang M; Chen J; Zhang L; Xiao Y; Wang L; Li Y; Yu L
    Leuk Lymphoma; 2021 Apr; 62(4):937-943. PubMed ID: 33225787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of AML 1/ETO fusion transcripts in patients with acute myelogenous leukemia.
    Cho EK; Bang SM; Ahn JY; Yoo SM; Park PW; Seo YH; Shin DB; Lee JH
    Korean J Intern Med; 2003 Mar; 18(1):13-20. PubMed ID: 12760263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pontin is a critical regulator for AML1-ETO-induced leukemia.
    Breig O; Bras S; Martinez Soria N; Osman D; Heidenreich O; Haenlin M; Waltzer L
    Leukemia; 2014 Jun; 28(6):1271-9. PubMed ID: 24342949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative effects of GM-CSF signaling in a murine model of t(8;21)-induced leukemia.
    Matsuura S; Yan M; Lo MC; Ahn EY; Weng S; Dangoor D; Matin M; Higashi T; Feng GS; Zhang DE
    Blood; 2012 Mar; 119(13):3155-63. PubMed ID: 22223820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.